| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 97.15B | 91.84B | 86.64B | 84.32B | 73.96B | 64.03B |
| Gross Profit | 46.12B | 42.61B | 38.65B | 35.01B | 30.38B | 26.56B |
| EBITDA | 20.13B | 17.78B | 15.65B | 12.94B | 10.31B | 9.19B |
| Net Income | 13.02B | 11.23B | 10.44B | 7.62B | 6.09B | 5.15B |
Balance Sheet | ||||||
| Total Assets | 128.01B | 124.61B | 121.72B | 116.74B | 109.04B | 102.54B |
| Cash, Cash Equivalents and Short-Term Investments | 40.01B | 43.66B | 38.22B | 33.82B | 28.11B | 25.33B |
| Total Debt | 875.00M | 1.52B | 1.77B | 2.65B | 2.63B | 2.60B |
| Total Liabilities | 18.54B | 18.57B | 21.87B | 27.83B | 25.90B | 23.84B |
| Stockholders Equity | 109.32B | 105.91B | 99.73B | 88.80B | 83.04B | 78.60B |
Cash Flow | ||||||
| Free Cash Flow | 12.47B | 11.84B | 9.39B | 4.83B | 1.47B | 3.71B |
| Operating Cash Flow | 15.69B | 14.59B | 12.12B | 8.25B | 5.63B | 8.80B |
| Investing Cash Flow | -5.41B | -1.75B | -3.71B | -1.08B | -1.65B | -5.35B |
| Financing Cash Flow | -13.56B | -7.61B | -7.20B | -3.33B | -3.27B | -4.48B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥38.40B | 8.57 | ― | 1.78% | -0.94% | 51.59% | |
79 Outperform | ¥96.79B | 14.20 | ― | 3.38% | 10.74% | -26.50% | |
73 Outperform | ¥315.78B | 21.53 | ― | 1.68% | 7.95% | 28.36% | |
73 Outperform | ¥55.23B | 13.47 | ― | 3.00% | 16.06% | 31.78% | |
67 Neutral | ¥159.21B | 6.77 | ― | 1.72% | 32.43% | 39.26% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
61 Neutral | ¥154.50B | 9.98 | ― | 2.42% | 9.74% | 6.48% |